buyWeak cluster of 410b5-1 plan
Krogulski Kenneth bought $9,106 of CPIX
director at CUMBERLAND PHARMACEUTICALS INC. 7,107 shares at an average of $1.28, traded Oct 1, 2024, filed Nov 5, 2024.
Conviction score
15Value
$9,106
7,107 shares
Holdings after
263,598
+3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-24-045328, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 1, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.27 | $392 | 256,800 | Nov 5, 2024 |
| Oct 2, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.29 | $399 | 257,109 | Nov 5, 2024 |
| Oct 3, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.28 | $396 | 257,418 | Nov 5, 2024 |
| Oct 4, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.28 | $396 | 257,727 | Nov 5, 2024 |
| Oct 7, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.29 | $399 | 258,036 | Nov 5, 2024 |
| Oct 8, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.30 | $402 | 258,345 | Nov 5, 2024 |
| Oct 9, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.31 | $405 | 258,654 | Nov 5, 2024 |
| Oct 10, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.32 | $408 | 258,963 | Nov 5, 2024 |
| Oct 11, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.39 | $430 | 259,272 | Nov 5, 2024 |
| Oct 14, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.37 | $423 | 259,581 | Nov 5, 2024 |
| Oct 15, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.30 | $402 | 259,890 | Nov 5, 2024 |
| Oct 16, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.25 | $386 | 260,199 | Nov 5, 2024 |
| Oct 17, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.30 | $402 | 260,508 | Nov 5, 2024 |
| Oct 18, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.28 | $396 | 260,817 | Nov 5, 2024 |
| Oct 21, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.25 | $386 | 261,126 | Nov 5, 2024 |
| Oct 22, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.25 | $386 | 261,435 | Nov 5, 2024 |
| Oct 23, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.26 | $389 | 261,744 | Nov 5, 2024 |
| Oct 24, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.24 | $383 | 262,053 | Nov 5, 2024 |
| Oct 25, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.23 | $380 | 262,362 | Nov 5, 2024 |
| Oct 28, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.25 | $386 | 262,671 | Nov 5, 2024 |
| Oct 29, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.24 | $383 | 262,980 | Nov 5, 2024 |
| Oct 30, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.32 | $408 | 263,289 | Nov 5, 2024 |
| Oct 31, 2024 | POpen-market purchase Common Stock10b5-1 | +309 | $1.20 | $371 | 263,598 | Nov 5, 2024 |
Related signals
Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth director | $8,209 | 4,716 | |
| 25Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J Chairman and CEO | $1,318 | 769 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Jones James director | $1,318 | 769 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Young Caroline director | $256 | 154 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth director | $9,348 | 8,029 | |
| 25Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J Chairman and CEO | $1,755 | 1,506 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Jones James director | $1,755 | 1,506 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Young Caroline director | $755 | 647 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J Chairman and CEO | $1,827 | 1,426 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Jones James director | $1,827 | 1,426 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.